Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $12,895 | $1,395 | $0 | $0 |
| % Growth | 824.4% | – | – | – |
| Cost of Goods Sold | $512 | $0 | $0 | $0 |
| Gross Profit | $12,383 | $1,395 | $0 | $0 |
| % Margin | 96% | 100% | – | – |
| R&D Expenses | $75,804 | $69,627 | $66,360 | $36,359 |
| G&A Expenses | $64,113 | $47,346 | $33,327 | $8,013 |
| SG&A Expenses | $64,113 | $47,346 | $33,327 | $8,013 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $627 | $0 | $0 | $0 |
| Operating Expenses | $140,544 | $116,973 | $99,687 | $44,372 |
| Operating Income | -$128,161 | -$115,578 | -$99,687 | -$44,372 |
| % Margin | -993.9% | -8,285.2% | – | – |
| Other Income/Exp. Net | $1,204 | $146 | $583 | $1,087 |
| Pre-Tax Income | -$126,957 | -$115,432 | -$99,104 | -$43,285 |
| Tax Expense | -$13,392 | -$1,000 | -$523 | -$1,087 |
| Net Income | -$113,565 | -$114,432 | -$98,581 | -$42,198 |
| % Margin | -880.7% | -8,203% | – | – |
| EPS | -1.52 | -1.81 | -1.88 | -1.04 |
| % Growth | 16% | 3.7% | -80.8% | – |
| EPS Diluted | -1.52 | -1.81 | -1.88 | -1.04 |
| Weighted Avg Shares Out | 74,723 | 63,101 | 52,457 | 40,747 |
| Weighted Avg Shares Out Dil | 74,723 | 63,101 | 52,457 | 40,747 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,241 | $146 | $583 | $1,087 |
| Interest Expense | $1,037 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,469 | $387 | $33 | -$16 |
| EBITDA | -$124,692 | -$115,191 | -$99,654 | -$44,372 |
| % Margin | -967% | -8,257.4% | – | – |